CGD Paper


Page Contents: Abstract | Summary Chart | Author Search |

Vu BG, Simonicova L, Moye-Rowley WS (2023) Calcineurin is required for Candida glabrata Pdr1 transcriptional activation. mBio :e0241623
Pubmed Entry


Abstract:Fluconazole is one of the most commonly used antifungals today. A result of this has been the inevitable selection of fluconazole-resistant organisms. This is an especially acute problem in the pathogenic yeast Candida glabrata. Elevated minimal inhibitory concentrations for fluconazole in C. glabrata are frequently associated with substitution mutations within the Zn2Cys6 zinc cluster-containing transcription factor-encoding gene PDR1. These mutant Pdr1 regulators drive constitutively high expression of target genes like CDR1 that encodes an ATP-binding cassette transporter thought to act as a drug efflux pump. Exposure of C. glabrata to fluconazole induced expression of both Pdr1 and CDR1, although little is known of the molecular basis underlying the upstream signals that trigger Pdr1 activation. Here, we show that the protein phosphatase calcineurin is required for fluconazole-dependent induction of Pdr1 transcriptional regulation. Calcineurin catalytic activity is required for normal Pdr1 regulation, and a hyperactive form of this phosphatase can decrease susceptibility to the echinocandin caspofungin but does not show a similar change for fluconazole susceptibility. Loss of calcineurin from strains expressing two different gain-of-function forms of Pdr1 also caused a decrease in CDR1 expression and increased fluconazole susceptibility, demonstrating that even these hyperactive Pdr1 regulatory mutants cannot bypass the requirement for calcineurin. Our data implicate calcineurin activity as a link tying azole and echinocandin susceptibility together via the control of transcription factor activity.IMPORTANCEDrug-resistant microorganisms are a problem in the treatment of all infectious diseases; this is an especially acute problem with fungi due to the existence of only three major classes of antifungal drugs, including the azole drug fluconazole. In the pathogenic yeast Candida glabrata, mutant forms of a transcription factor called Pdr1 are commonly associated with decreased fluconazole susceptibility and poor clinical outcomes. Here, we identify a protein phosphatase called calcineurin that is required for fluconazole-dependent induction of Pdr1 transcriptional activation and associated drug susceptibility. Gain-of-function mutant forms of Pdr1 still required the presence of calcineurin to confer normally decreased fluconazole susceptibility. Previous studies showed that calcineurin controls susceptibility to the echinocandin class of antifungal drugs, and our data demonstrate that this protein phosphatase is also required for normal azole drug susceptibility. Calcineurin plays a central role in susceptibility to two of the three major classes of antifungal drugs in C. glabrata.
Status: Epub ahead of print Type: Journal Article PubMed ID: 37943042


Topics addressed in this paper
  • To find other papers on a gene and topic, click on the colored ball in the appropriate box.
    displays other papers with information about that topic for that gene.
    displays other papers in CGD that are associated with that topic.
    The topic is addressed in these papers but does not describe a specific gene or chromosomal feature.

  • To go to the Locus page for a gene, click on the gene name.

Topics
Genes linked to topics
CDR1
(C. glabrata)
CNA1
(C. glabrata)
CNB1
(C. glabrata)
PDR1
(C. glabrata)
Genetic Interactions

Genomic co-immunoprecipitation study

Mutants/Phenotypes

Protein Levels

RNA Levels and Processing

Sensitivity/response to drugs/other treatments
Author Searches
To find contact information or other publications by the authors of this paper, follow these three steps:

(1) Choose an author, (2) Choose a search parameter, (3) Click to implement.




AltStyle によって変換されたページ (->オリジナル) /